These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1172193)

  • 1. Morphine withdrawal response and central cholinergic activity.
    Frederickson RC
    Nature; 1975 Sep; 257(5522):131-2. PubMed ID: 1172193
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptive cholinergic-dopaminergic responses in morphine dependence.
    Way EL; Iwamoto ET; Bhargava HN; Loh HH
    Adv Biochem Psychopharmacol; 1975; 13():169-84. PubMed ID: 1171581
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of cholinergic drugs on acute and chronic morphine dependence.
    Padmanabha Pillai N; Ramaswamy S; Gopalakrishnan V; Ghosh MN
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):146-54. PubMed ID: 7202346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of precipitated morphine withdrawal syndrome by drugs affecting cholinergic mechanisms.
    Jhamandas K; Sutak M; Bell S
    Eur J Pharmacol; 1973 Dec; 24(3):296-305. PubMed ID: 4148842
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial inhibition of the abstinence syndrome in morphine tolerant-dependent mice following pharmacological denervation.
    Contreras E; Tamayo L; Quijada L
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):124-33. PubMed ID: 310664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists.
    Bhargava HN; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of the central cholinergic and endorphinergic systems in the nitrous oxide withdrawal syndrome in mice.
    Rupreht J; Dworacek B; Ducardus R; Schmitz PI; Dzoljic MR
    Anesthesiology; 1983 Jun; 58(6):524-6. PubMed ID: 6683088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cholinergic and anticholinergic drugs and a partial cholinergic agonist on the development and expression of physical dependence on morphine in rat.
    Frederickson RC; Pinsky C
    J Pharmacol Exp Ther; 1975 Apr; 193(1):44-55. PubMed ID: 1169318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal cholinergic neurons and the expression of morphine withdrawal symptoms in the rat.
    Marshall DC; Buccafusco JJ
    J Neurosci; 1987 Mar; 7(3):621-8. PubMed ID: 3559705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aging on morphine withdrawal in the rat.
    Simpkins JW
    Exp Gerontol; 1994; 29(1):67-76. PubMed ID: 8187842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of muscarinic cholinergic involvement in the antinociceptive effects of morphine and clonidine in the mouse.
    Lipman JJ; Spencer PS
    Eur J Pharmacol; 1980 Jun; 64(4):249-58. PubMed ID: 7389822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine abstinence syndrome: cholinergic mechanisms in the ventral periaqueductal gray of the dog.
    Sharpe LG; Pickworth WB
    NIDA Res Monogr; 1984 Mar; 49():143-9. PubMed ID: 6434952
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain acetylcholine during morphine withdrawal.
    Crossland J; Ahmed KZ
    Neurochem Res; 1984 Mar; 9(3):351-66. PubMed ID: 6539857
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
    Buccafusco JJ; Zhang LC; Shuster LC; Jonnala RR; Gattu M
    Brain Res; 2000 Jan; 852(1):76-83. PubMed ID: 10661498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opiate quasiwithdrawal syndrome in rhesus monkeys: comparison of naloxone-precipitated withdrawal to effects of cholinergic agents.
    Katz JL; Valentino RJ
    Psychopharmacology (Berl); 1984; 84(1):12-5. PubMed ID: 6436878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of cholinergic transmission at the spinal level to opiate effectiveness.
    Dirksen R; Nijhuis GM
    Eur J Pharmacol; 1983 Jul; 91(2-3):215-21. PubMed ID: 6617742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
    Iwamoto ET; Ho IK; Way EL
    J Pharmacol Exp Ther; 1973 Dec; 187(3):588-67. PubMed ID: 4797745
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of cholinergic agonists and antagonists on morphine-withdrawal syndrome.
    Hynes MD; Gianutsos G; Lal H
    Psychopharmacology (Berl); 1976 Sep; 49(2):191-5. PubMed ID: 825907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine.
    Mundey MK; Mason R; Wilson VG
    Br J Pharmacol; 1998 Jul; 124(5):911-6. PubMed ID: 9692776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine.
    Rada P; Pothos E; Mark GP; Hoebel BG
    Brain Res; 1991 Oct; 561(2):354-6. PubMed ID: 1802350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.